TUESDAY, Dec. 19, 2017 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday called for tougher warnings and “additional research” into a dye commonly used with standard MRIs.
The dye — a “contrast agent” — contains a metal called gadolinium. It made news recently after claims from actor Chuck Norris that its use during MRI scans seriously affected his wife’s brain.
Contrast agents are injected into the body during an MRI scan to enhance image quality.
In November, Norris and his wife, Gena, filed a lawsuit against several medical companies alleging she fell ill after exposure to gadolinium during MRI scans.
The suit said Gena Norris was left weak, tired and suffering bouts of pain and burning sensations.
After reviewing available data, the FDA on Tuesday recommended that radiologists consider how much gadolinium might be left behind in a patient’s body when selecting a gadolinium-based contrast agent [GBCA] for an MRI.